CAGRILINTIDE ACETATE

Description

CAGRILINTIDE ACETATE – DRAGON PHARMA 1 vial x 10 mg Cagrilintide Acetate Cagrilintide acetate is a non-selective agonist of the amylin receptor (AMYR) and calcitonin receptor (CTR), as well as a long-acting, acylated analogue of amylase. This compound has been shown to reduce food intake and induce significant, dose-dependent weight loss. Additionally, it enhances insulin sensitivity and improves glycemic control, offering potential therapeutic benefits for patients with type 2 diabetes, which is frequently associated with obesity. Cagrilintide’s dual effects on weight reduction and glucose regulation position it as a promising candidate in the management of metabolic disorders.